Palantir and OneMedNet Partner to Enhance Healthcare Data Platform with AI Technology.
PorAinvest
lunes, 6 de octubre de 2025, 4:26 pm ET1 min de lectura
ONMD--
OneMedNet CEO Aaron Green stated, "Palantir's system revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." This partnership comes at a critical juncture as access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 2030. By leveraging Palantir's software, OneMedNet can combine its expansive provider network with Palantir's advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform [1].
Under the multi-year agreement, Palantir's AI platform will integrate with OneMedNet's network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases. This integration will enable faster data discovery, accurate data delivery, and increased productivity, among other benefits [1].
Despite recent revenue declines, OneMedNet shares have risen over 100% in six months, reflecting investor confidence in the company's ability to leverage cutting-edge technology to drive growth and innovation in the healthcare sector. The partnership with Palantir Technologies is expected to further bolster OneMedNet's position in the market, as it continues to expand its market reach and independently broaden its global footprint [1].
PLTR--
OneMedNet has partnered with Palantir Technologies to enhance its healthcare data platform using Palantir's AI tools. The platform will deliver anonymized data to life sciences and research organizations, speeding up medical studies and product development. OneMedNet CEO Aaron Green said Palantir's system "revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." Despite recent revenue declines, OneMedNet shares have risen over 100% in six months.
OneMedNet Corporation has announced a strategic partnership with Palantir Technologies to enhance its healthcare data platform using Palantir's AI tools. This collaboration aims to deliver anonymized data to life sciences and research organizations, significantly speeding up medical studies and product development. The integration of Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's near real-time AI-powered provider network, enabling the company to empower life sciences, medical device, and research organizations with regulatory-grade clinical data and advanced analytics [1].OneMedNet CEO Aaron Green stated, "Palantir's system revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." This partnership comes at a critical juncture as access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 2030. By leveraging Palantir's software, OneMedNet can combine its expansive provider network with Palantir's advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform [1].
Under the multi-year agreement, Palantir's AI platform will integrate with OneMedNet's network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases. This integration will enable faster data discovery, accurate data delivery, and increased productivity, among other benefits [1].
Despite recent revenue declines, OneMedNet shares have risen over 100% in six months, reflecting investor confidence in the company's ability to leverage cutting-edge technology to drive growth and innovation in the healthcare sector. The partnership with Palantir Technologies is expected to further bolster OneMedNet's position in the market, as it continues to expand its market reach and independently broaden its global footprint [1].

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios